Senior insider sale
Chief Business Officer at OVID THERAPEUTICS INC. — senior position signals high conviction
$1.34M
475K shares
What this filing means
RONA JEFFREY A plans to sell 475K shares of OVID THERAPEUTICS INC. valued at approximately $1.34M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/24/2026ACC: 0001311404-26-000007
Officer· Chief Business Officer
Since Sep 2020
475K
Shares to sell
$1.34M
Approx. market value
325K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/24/2026
325KTotal acquired325K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/24/2026 | Stock Option Exercise Cash | 325K | — |
| Total | 325K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
37.47K
Market value
$108.7K
8/19/2026
—Completed
Units to sell
60K
Market value
$169.8K
8/18/2026
—Completed
Units to sell
52.53K
Market value
$150.0K
8/17/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
325K
Market value
$910.0K
8/24/2026
Total
Units
475K
Value
$1.34M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/19/2026 | 37.47K | $108.7K | — | Completed |
8/18/2026 | 60K | $169.8K | — | Completed |
8/17/2026 | 52.53K | $150.0K | — | Completed |
| Planned — Approximate Date | ||||
8/24/2026 | 325K | $910.0K | Nasdaq | Planned |
| Total | 475K | $1.34M | ||